New drug shows promise for shrinking painful NF1 tumors in early trial
Disease control
Recruiting now
This study tests an experimental drug called HLX-1502 in people aged 12 and older with neurofibromatosis type 1 (NF1) who have growing or symptomatic plexiform neurofibromas (nerve tumors). The main goal is to see if the drug can shrink these tumors by at least 20%. Researchers w…
Phase: PHASE2 • Sponsor: Healx Limited • Aim: Disease control
Last updated May 04, 2026 16:20 UTC